Oklahoma State University announced the retirement of Dr Anil Kaul, an Indian American clinical professor and program director of global health at the university’s Center for Health Sciences (OSU-CHS) after 17 years of service.
During his tenure at OSU, Kaul made significant contributions to global and public health and played a pivotal role in Oklahoma’s COVID-19 testing services.
Having joined the university in 2007, Kaul established a clinical laboratory that evolved into the High-Complexity Diagnostic Laboratory. He also developed the master's degree program in global health under the School of Health Care Administration.
During the COVID-19 pandemic, Kaul's laboratory became crucial for rapid testing, significantly aiding the state’s response. “It was a privilege to volunteer and serve our community during the COVID pandemic,” Kaul remarked.
Kaul has over 100 publications, five patents, and has received several awards, including the Expeditionary Service Award from the U.S. Secretary of State. He emphasized the importance of global health, stating that the health of individuals is influenced by global factors.
His career at OSU-CHS includes extensive global health work, international training of healthcare workers, and over 100 research publications. He has received numerous accolades, including the Expeditionary Service Award from the U.S. Secretary of State and a Lifetime Achievement Award at the Indo-Global Healthcare Summit.
Reflecting on his tenure, Kaul said, "OSU has been like a family, and the Tulsa community has been incredibly supportive. I will miss teaching and mentoring our students, but I will continue to pursue these goals even during my retirement."
Kaul, who hails from Kashmir, India, was inspired by his father, a maxillofacial surgeon, to pursue a career in medicine. He completed his education at Madras Medical College and King George's Medical University in India, and furthered his training in obstetrics and gynecology at the University of Texas Medical Branch in Galveston.
ADVERTISEMENT
ADVERTISEMENT
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login